News

Comprehend recently released a survey of over 100 Clinical Operations leaders providing consensus on their goals, challenges and best practices for CRO Oversight.

DrugDev has announced the acquisition of SecureConsent, a provider of electronic informed consent solutions.

TransCelerate’s recently published article in a DIA publication covered issues management in clinical trial Quality Management Systems (QMS). Abbvie’s Susan Callery-D’Amico speaks to us about TransCelerate’s QMS Initiative and Issue Management.

Have the roles of the monitor advanced? How are CRAs accepting the change? How is pharma implementing RBM-is it more remote, centralized or a combination? How important is eSource to RBM? This eBook will highlight articles that answer these question.

A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising.

The European Medicines Agency (EMA) has released an update on its plans to revise the existing guideline on first-in-human clinical trials.

The Society for Clinical Research Sites (SCRS) has announced GlaxoSmithKline (GSK) as its newest Global Impact Partner (GIP).

Schulman IRB and iMedRIS Data Corporation announce a partnership to provide research organizations with integrated technology, consulting and IRB review services.

The American Heart Association (AHA) has announced the launch of a cloud-based Precision Medicine Platform in collaboration with Amazon Web Services (AWS).

PAREXEL has launched an Identification of Medicinal Products (IDMP)-focused solution, Liquent InSight, for biopharma companies.

Clinical Research IO (CRIO) is a website and Android app that allows users to conducts trial visits on a tablet or desktop, design source online, manage and schedule subjects and communicate with study monitors remotely.

A new group of collaborators has formed to determine the benefits and risk tradeoffs Parkinson’s disease patients are willing to make for a potential new therapy. Dr. Brett Hauber of RTI Health Solutions spoke to us about the collaborative.

The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial.

CluePoints announced a partnership with the Metrics Champion Consortium, an association that develops standardized performance metrics to improve clinical trials.

INC Research announces its involvement in the Leukemia & Lymphoma Society’s (LLS) precision medicine Master Trial for the treatment of acute myeloid leukemia (AML).